Syndax Pharmaceuticals Inc banner

Syndax Pharmaceuticals Inc
F:1T3

Watchlist Manager
Syndax Pharmaceuticals Inc Logo
Syndax Pharmaceuticals Inc
F:1T3
Watchlist
Price: 17.67 EUR 3.85% Market Closed
Market Cap: €1.5B

Wall St Price Targets

1T3 Price Targets Summary
Syndax Pharmaceuticals Inc

Wall Street analysts forecast 1T3 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 1T3 is 26.92 EUR with a low forecast of 19.07 EUR and a high forecast of 38.96 EUR.

Lowest Forecast
Price Target
19.07 EUR
8% Upside
Average Forecast
Price Target
26.92 EUR
52% Upside
Highest Forecast
Price Target
38.96 EUR
120% Upside
Syndax Pharmaceuticals Inc Competitors:
Price Targets
CFFN
Capitol Federal Financial Inc
14% Upside
JACK
Jack in the Box Inc
-1% Downside
4966
Parade Technologies Ltd
16% Upside

Revenue
Forecast

N/A
Past Growth
34% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
N/A
Past Growth
34% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

The compound annual growth rate for Revenue over the next 8 years is 34%.

Gross Profit
Forecast

N/A
Past Growth
31% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
31% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

The compound annual growth rate for Gross Profit over the next 8 years is 31%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 1T3's stock price target?
Price Target
26.92 EUR

According to Wall Street analysts, the average 1-year price target for 1T3 is 26.92 EUR with a low forecast of 19.07 EUR and a high forecast of 38.96 EUR.

What is the Revenue forecast for Syndax Pharmaceuticals Inc?
Projected CAGR
34%

The compound annual growth rate for Revenue over the next 8 years is 34%.

What is the Gross Profit forecast for Syndax Pharmaceuticals Inc?
Projected CAGR
31%

The compound annual growth rate for Gross Profit over the next 8 years is 31%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett